Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA

Neuropharmacology ◽

10.1016/j.neuropharm.2013.07.016 ◽

2014 ◽

Vol 76 ◽

pp. 156-168 ◽

Cited By ~ 28

Author(s):

Antonio Dominguez-Meijide ◽

Begoña Villar-Cheda ◽

Pablo Garrido-Gil ◽

German Sierrra-Paredes ◽

Maria J. Guerra ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Chronic Treatment ◽

Striatal Dopamine ◽

Receptor Antagonists ◽

Angiotensin Type

Download Full-text

Effects of Angiotensin Type 1 Receptor Antagonists on Parkinson’s Disease Progression: an exploratory study in the PPMI database

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2021.03.007 ◽

2021 ◽

Author(s):

Lucas Udovin ◽

Matilde Otero-Losada ◽

Sofia Bordet ◽

Guenson Chevalier ◽

Cecilia Quarracino ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Disease Progression ◽

Exploratory Study ◽

Receptor Antagonists ◽

Angiotensin Type

Download Full-text

Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease

Synapse ◽

10.1002/(sici)1098-2396(199902)31:2<134::aid-syn6>3.0.co;2-v ◽

1999 ◽

Vol 31 (2) ◽

pp. 134-139 ◽

Cited By ~ 35

Author(s):

Sylvie Chalon ◽

Patrick Emond ◽

Sylvie Bodard ◽

Marie-Paule Vilar ◽

Cynthia Thiercelin ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Time Course ◽

D2 Receptors ◽

Striatal Dopamine ◽

Dopamine Transporters

Download Full-text

Steroidal anti inflammatory drug betamethasone significantly alters level of striatal dopamine in a rat model of Parkinson’s disease

Nature Precedings ◽

10.1038/npre.2008.2330.1 ◽

2008 ◽

Author(s):

Mehdi Shafiee Ardestani ◽

Hasan Mehrab ◽

Amin Geravand ◽

Nasir Mohajer ◽

Mostafa Saffari

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Striatal Dopamine ◽

Inflammatory Drug ◽

Anti Inflammatory

Download Full-text

Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

Experimental Neurology ◽

10.1016/j.expneurol.2014.08.019 ◽

2014 ◽

Vol 261 ◽

pp. 720-732 ◽

Cited By ~ 33

Author(s):

Ana Muñoz ◽

Pablo Garrido-Gil ◽

Antonio Dominguez-Meijide ◽

Jose L. Labandeira-Garcia

Keyword(s):

Parkinson’S Disease ◽

Vascular Endothelial Growth Factor ◽

Parkinson's Disease ◽

Growth Factor ◽

Interleukin 1Β ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Angiotensin Type

Download Full-text

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

Journal of Neuroinflammation ◽

10.1186/1742-2094-9-38 ◽

2012 ◽

Vol 9 (1) ◽

Cited By ~ 58

Author(s):

Pablo Garrido-Gil ◽

Belen Joglar ◽

Ana I Rodriguez-Perez ◽

Maria J Guerra ◽

Jose L Labandeira-Garcia

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Receptor Antagonist ◽

Ppar Γ ◽

Receptor Inhibition ◽

Anti Inflammatory ◽

Mptp Model ◽

Angiotensin Type

Download Full-text

P.1.g.008 Levodopa chronic treatment promotes reinforcing properties of pramipexole in alpha-synuclein rat model of Parkinson's disease

European Neuropsychopharmacology ◽

10.1016/s0924-977x(15)30268-6 ◽

2015 ◽

Vol 25 ◽

pp. S242

Author(s):

S. Loiodice ◽

A. Hafidi ◽

F. Durif

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Chronic Treatment ◽

Alpha Synuclein

Download Full-text

Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease

Synapse ◽

10.1002/syn.20410 ◽

2007 ◽

Vol 61 (8) ◽

pp. 606-614 ◽

Cited By ~ 62

Author(s):

Annalisa Pinna ◽

Silvia Pontis ◽

Franco Borsini ◽

Micaela Morelli

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Adenosine A2a Receptor ◽

Receptor Antagonists ◽

Adenosine A2a Receptor Antagonists ◽

A2a Receptor ◽

Sensory Motor ◽

6 Hydroxydopamine ◽

Adenosine A2a

Download Full-text

Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson’s disease

Brain Research ◽

10.1016/j.brainres.2020.147266 ◽

2021 ◽

pp. 147266

Author(s):

Yong Wang ◽

Lu Yao ◽

Shasha Gao ◽

Gejuan Zhang ◽

Qiongchi Zhang ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Striatal Dopamine ◽

Dopamine D5 Receptor

Download Full-text

Rasagiline Reduces Striatal Dopamine Release and Extracellular Oxidative Stress in a Rat Model of Early Parkinson’s Disease

Catecholamine Research in the 21st Century ◽

10.1016/b978-0-12-800044-1.00125-2 ◽

2014 ◽

pp. 141

Author(s):

Y. Aluf ◽

J. Vaya ◽

S. Khatib ◽

J.P.M Finberg

Keyword(s):

Oxidative Stress ◽

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Dopamine Release ◽

Striatal Dopamine ◽

Striatal Dopamine Release ◽

Early Parkinson’S Disease

Download Full-text

Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson’s disease

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2015.10.592 ◽

2016 ◽

Vol 22 ◽

pp. e86

Author(s):

Anne Michel ◽

Patrick Downey ◽

Jean-marie Nicolas ◽

Dieter Scheller

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Therapeutic Potential ◽

Receptor Antagonists ◽

Nr2b Receptor

Download Full-text